Scholar Rock Holding (SRRK) Revenue (2019 - 2022)
Scholar Rock Holding's (SRRK) quarterly Revenue came in at $33.2 million in Q1 2022, up 605.03% year-on-year from $4.7 million in Q1 2021, and up 719.78% quarter-over-quarter from $4.0 million in Q4 2021.
Scholar Rock Holding (SRRK) Revenue (2019 - 2022) Analysis & Trends
Scholar Rock Holding's Revenue history runs 4 years deep, the most recent figure standing at $33.2 million for Q1 2022.
- On a quarterly basis, Revenue rose 605.03% year-over-year to $33.2 million in Q1 2022; TTM through Dec 2022 was $33.2 million, a 76.41% increase from a year earlier, with the FY2022 full-year figure at $33.2 million, up 76.41% from the prior year.
- Revenue improved to $33.2 million in Q1 2022 per SRRK's latest filing, from $4.0 million in the prior quarter.
- Across five years, Revenue topped out at $33.2 million in Q1 2022 and bottomed at $3.0 million in Q3 2020.
- The 4-year median for Revenue is $4.7 million (2021), against an average of $6.8 million.
- Across the five-year window, Revenue tumbled 54.63% in 2020 and jumped 605.03% in 2022, its largest moves.
- Year by year, Revenue stood at $7.6 million in 2019, then tumbled by 54.63% to $3.4 million in 2020, then grew by 17.84% to $4.0 million in 2021, then surged by 719.78% to $33.2 million in 2022.
- Per Business Quant, the three latest SRRK Revenue figures stand at $33.2 million (Q1 2022), $4.0 million (Q4 2021), and $5.5 million (Q3 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Scholar Rock Holding | 6.10 Bn | 6.10 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 33.19 Mn |
| Dec 31, 2021 | 4.05 Mn |
| Sep 30, 2021 | 5.46 Mn |
| Jun 30, 2021 | 4.60 Mn |
| Mar 31, 2021 | 4.71 Mn |
| Dec 31, 2020 | 3.44 Mn |
| Sep 30, 2020 | 3.04 Mn |
| Jun 30, 2020 | 3.90 Mn |
| Mar 31, 2020 | 5.03 Mn |
| Dec 31, 2019 | 7.57 Mn |
| Sep 30, 2019 | 4.77 Mn |
| Jun 30, 2019 | 5.04 Mn |
| Mar 31, 2019 | 3.11 Mn |